{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:30:11Z","timestamp":1789957811260,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T00:00:00Z","timestamp":1490832000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s12149-017-1166-3","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T00:23:08Z","timestamp":1490833388000},"page":"390-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Correlation between clinical symptoms and striatal DAT uptake in patients with DLB"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1324-1973","authenticated-orcid":false,"given":"Soichiro","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disuke","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayuta","family":"Namioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Kanetaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Hirao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokuni","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Takenoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Umahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruo","family":"Hanyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,30]]},"reference":[{"key":"1166_CR1","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863\u201372.","journal-title":"Neurology"},{"key":"1166_CR2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","volume":"15","author":"TS Benamer","year":"2000","unstructured":"Benamer TS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord. 2000;15:503\u201310.","journal-title":"Mov Disord"},{"key":"1166_CR3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s002590000460","volume":"28","author":"J Booij","year":"2001","unstructured":"Booij J, Speelman JD, Horstink MW, Wolters EC. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med. 2001;28:266\u201372.","journal-title":"Eur J Nucl Med"},{"key":"1166_CR4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.parkreldis.2006.10.009","volume":"13","author":"K Ashkan","year":"2007","unstructured":"Ashkan K, Wallace BA, Mitrofanis J, Pollo C, Brard PY, Fagret D, et al. SPECT imaging, immunohistochemical and behavioural correlations in the primate models of Parkinson\u2019s disease. Parkinsonism Relat Disord. 2007;13:266\u201375.","journal-title":"Parkinsonism Relat Disord"},{"key":"1166_CR5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1471-4159.2009.05904.x","volume":"109","author":"V Sossi","year":"2009","unstructured":"Sossi V, Dinelle K, Topping GJ, Holden JE, Doudet D, Schulzer M, et al. Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson\u2019s: an in vivo imaging study. J Neurochem. 2009;109:85\u201392.","journal-title":"J Neurochem"},{"key":"1166_CR6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/jnnp.73.2.134","volume":"73","author":"Z Walker","year":"2002","unstructured":"Walker Z, Costa DC, Walker RW, Shaw K, Gacinovic S, Stevens T, et al. Differentiation of dementia with Lewy bodies from Alzheimer\u2019s disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry. 2002;73:134\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1166_CR7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","volume":"6","author":"I McKeith","year":"2007","unstructured":"McKeith I, O\u2019Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6:305\u201313.","journal-title":"Lancet Neurol"},{"key":"1166_CR8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archneur.61.6.919","volume":"61","author":"JT O\u2019Brien","year":"2004","unstructured":"O\u2019Brien JT, Colloby S, Fenwick J, Williams ED, Firbank M, Burn D, et al. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol. 2004;61:919\u201325.","journal-title":"Arch Neurol"},{"key":"1166_CR9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.parkreldis.2011.09.015","volume":"18","author":"ND Papathanasiou","year":"2012","unstructured":"Papathanasiou ND, Boutsiadis A, Dickson J, Bomanji JB. Diagnostic accuracy of \u00b9\u00b2\u00b3I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies. Parkinsonism Relat Disord. 2012;18:225\u20139.","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 12","key":"1166_CR10","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1002\/mds.20538","volume":"20","author":"GK Tofaris","year":"2005","unstructured":"Tofaris GK, Spillantini MG. Alpha-synuclein dysfunction in Lewy body diseases. Mov Disord. 2005;20(Suppl 12):S37\u201344.","journal-title":"Mov Disord"},{"key":"1166_CR11","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/01.WNL.0000123248.39847.1D","volume":"62","author":"Z Walker","year":"2004","unstructured":"Walker Z, Costa DC, Walker RW, Lee L, Livingston G, Jaros E, et al. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison. Neurology. 2004;62:1568\u201372.","journal-title":"Neurology"},{"key":"1166_CR12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00259-011-1976-9","volume":"39","author":"M Ziebell","year":"2012","unstructured":"Ziebell M, Andersen BB, Thomsen G, Pinborg LH, Karlsborg M, Hasselbalch SG, et al. Predictive value of dopamine transporter SPECT imaging with [\u00b9\u00b2\u00b3I]PE2I in patients with subtle parkinsonian symptoms. Eur J Nucl Med Mol Imaging. 2012;39:242\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1166_CR13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1192\/bjp.bp.114.148643","volume":"206","author":"Z Walker","year":"2015","unstructured":"Walker Z, Moreno E, Thomas A, Inglis F, Tabet N, Rainer M, et al. Clinical usefulness of dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible dementia with Lewy bodies: randomised study. Br J Psychiatry. 2015;206:145\u201352.","journal-title":"Br J Psychiatry"},{"key":"1166_CR14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-3-7091-6842-4_2","volume":"50","author":"T Br\u00fccke","year":"1997","unstructured":"Br\u00fccke T, Asenbaum S, Pirker W, Djamshidian S, Wenger S, W\u00f6ber C, et al. Measurement of the dopaminergic degeneration in Parkinson\u2019s disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J Neural Transm Suppl. 1997;50:9\u201324.","journal-title":"J Neural Transm Suppl"},{"key":"1166_CR15","first-page":"69","volume":"6","author":"DJ Brooks","year":"1997","unstructured":"Brooks DJ. PET and SPECT studies in Parkinson\u2019s disease. Baillieres Clin Neurol. 1997;6:69\u201387.","journal-title":"Baillieres Clin Neurol"},{"key":"1166_CR16","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V","volume":"15","author":"HT Benamer","year":"2000","unstructured":"Benamer HT, Patterson J, Wyper DJ, Hadley DM, Macphee GJ, Grosset DG. Correlation of Parkinson\u2019s disease severity and duration with 123I-FP-CIT SPECT striatal uptake. Mov Disord. 2000;15:692\u20138.","journal-title":"Mov Disord"},{"issue":"Suppl 7","key":"1166_CR17","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/mds.10581","volume":"18","author":"PK Morrish","year":"2003","unstructured":"Morrish PK. How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson\u2019s disease? Mov Disord. 2003;18(Suppl 7):S63\u201370.","journal-title":"Mov Disord"},{"key":"1166_CR18","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/mds.22702","volume":"24","author":"F Roselli","year":"2009","unstructured":"Roselli F, Pisciotta NM, Perneczky R, Pennelli M, Aniello MS, De Caro MF, et al. Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study. Mov Disord. 2009;24:2097\u2013103.","journal-title":"Mov Disord"},{"key":"1166_CR19","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.2967\/jnumed.112.114025","volume":"54","author":"M Ziebell","year":"2013","unstructured":"Ziebell M, Andersen BB, Pinborg LH, Knudsen GM, Stokholm J, Thomsen G, et al. Striatal dopamine transporter binding does not correlate with clinical severity in dementia with Lewy bodies. J Nucl Med. 2013;54:1072\u20136.","journal-title":"J Nucl Med"},{"key":"1166_CR20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s00259-016-3466-6","volume":"44","author":"K Kasanuki","year":"2017","unstructured":"Kasanuki K, Iseki E, Ota K, Kondo D, Ichimiya Y, Sato K, et al. (123)I-FP-CIT SPECT findings and its clinical relevance in prodromal dementia with Lewy bodies. Eur J Nucl Med Mol Imaging. 2017;44:358\u201365.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1166_CR21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/mds.26327","volume":"31","author":"FJ Siepel","year":"2016","unstructured":"Siepel FJ, Dalen I, Gr\u00fcner R, Booij J, Br\u00f8nnick KS, Buter TC, et al. Loss of dopamine transporter binding and clinical symptoms in dementia with Lewy bodies. Mov Disord. 2016;31:118\u201325.","journal-title":"Mov Disord"},{"key":"1166_CR22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","volume":"140","author":"CP Hughes","year":"1982","unstructured":"Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566\u201372.","journal-title":"Br J Psychiatry"},{"key":"1166_CR23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398.","journal-title":"J Psychiatr Res"},{"key":"1166_CR24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984;34:939\u201344.","journal-title":"Neurology"},{"key":"1166_CR25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2967\/jnumed.111.100784","volume":"53","author":"DS Djang","year":"2012","unstructured":"Djang DS, Janssen MJ, Bohnen N, Booij J, Henderson TA, Herholz K, et al. SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0. J Nucl Med. 2012;53:154\u201363.","journal-title":"J Nucl Med"},{"key":"1166_CR26","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archneur.1975.00490510088009","volume":"32","author":"VC Hachinski","year":"1975","unstructured":"Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, et al. Cerebral blood flow in dementia. Arch Neurol. 1975;32:632\u20137.","journal-title":"Arch Neurol"},{"key":"1166_CR27","first-page":"165","volume":"39","author":"SE Daniel","year":"1993","unstructured":"Daniel SE, Lees AJ. Parkinson\u2019s Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl. 1993;39:165\u201372.","journal-title":"J Neural Transm Suppl"},{"key":"1166_CR28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427\u201342.","journal-title":"Neurology"},{"key":"1166_CR29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12149-011-0564-1","volume":"26","author":"N Papathanasiou","year":"2012","unstructured":"Papathanasiou N, Rondogianni P, Chroni P, Themistocleous M, Boviatsis E, Pedeli X, et al. Interobserver variability, and visual and quantitative parameters of (123)I-FP-CIT SPECT (DaTSCAN) studies. Ann Nucl Med. 2012;26:234\u201340.","journal-title":"Ann Nucl Med"},{"key":"1166_CR30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00259-012-2276-8","volume":"40","author":"A Varrone","year":"2013","unstructured":"Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, et al. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur J Nucl Med Mol Imaging. 2013;40:213\u201327.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"1166_CR31","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ. Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain. 1991;114(Pt 5):2283\u2013301.","journal-title":"Brain"},{"key":"1166_CR32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00259-012-2304-8","volume":"40","author":"F Nobili","year":"2013","unstructured":"Nobili F, Naseri M, De Carli F, Asenbaum S, Booij J, Darcourt J, et al. Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database. Eur J Nucl Med Mol Imaging. 2013;40:565\u201373.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1166_CR33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s007020050140","volume":"106","author":"TA Ala","year":"1999","unstructured":"Ala TA, Yang KH, Sung JH, Frey WH. Clinical parkinsonism in dementia patients with substantia nigra Lewy bodies. J Neural Transm (Vienna). 1999;106:47\u201357.","journal-title":"J Neural Transm (Vienna)"},{"issue":"Suppl 7","key":"1166_CR34","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1002\/mds.10576","volume":"18","author":"DC Costa","year":"2003","unstructured":"Costa DC, Walker Z, Walker RW, Fontes FR. Dementia with Lewy bodies versus Alzheimer\u2019s disease: role of dopamine transporter imaging. Mov Disord. 2003;18(Suppl 7):S34\u20138.","journal-title":"Mov Disord"},{"key":"1166_CR35","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","volume":"47","author":"IG McKeith","year":"1996","unstructured":"McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113\u201324.","journal-title":"Neurology"},{"key":"1166_CR36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1148\/radiology.214.1.r00ja43227","volume":"214","author":"JW Burruss","year":"2000","unstructured":"Burruss JW, Hurley RA, Taber KH, Rauch RA, Norton RE, Hayman LA. Functional neuroanatomy of the frontal lobe circuits. Radiology. 2000;214:227\u201330.","journal-title":"Radiology"},{"key":"1166_CR37","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.neurobiolaging.2007.12.001","volume":"30","author":"R Perneczky","year":"2009","unstructured":"Perneczky R, Drzezga A, Boecker H, Wagenpfeil S, F\u00f6rstl H, Kurz A, et al. Right prefrontal hypometabolism predicts delusions in dementia with Lewy bodies. Neurobiol Aging. 2009;30:1420\u20139.","journal-title":"Neurobiol Aging"},{"key":"1166_CR38","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1212\/WNL.58.10.1489","volume":"58","author":"JO Rinne","year":"2002","unstructured":"Rinne JO, Laine M, Kaasinen V, Norvasuo-Heil\u00e4 MK, N\u00e5gren K, Helenius H. Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia. Neurology. 2002;58:1489\u201393.","journal-title":"Neurology"},{"key":"1166_CR39","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000105159","volume":"4","author":"F Sedaghat","year":"2007","unstructured":"Sedaghat F, Gotzamani-Psarrakou A, Dedousi E, Arnaoutoglou M, Psarrakos K, Baloyannis I, et al. Evaluation of dopaminergic function in frontotemporal dementia using I-FP-CIT single photon emission computed tomography. Neurodegener Dis. 2007;4:382\u20135.","journal-title":"Neurodegener Dis"},{"key":"1166_CR40","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1136\/jnnp-2012-302577","volume":"83","author":"S Morgan","year":"2012","unstructured":"Morgan S, Kemp P, Booij J, Costa DC, Padayachee S, Lee L, et al. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT. J Neurol Neurosurg Psychiatry. 2012;83:1063\u201370.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1166_CR41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359.","journal-title":"Acta Neuropathol"},{"key":"1166_CR42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/WAD.0b013e31824acd84","volume":"27","author":"IU Song","year":"2013","unstructured":"Song IU, Kim YD, Cho HJ, Chung SW, Chung YA. An FP-CIT PET comparison of the differences in dopaminergic neuronal loss between idiopathic Parkinson disease with dementia and without dementia. Alzheimer Dis Assoc Disord. 2013;27:51\u20135.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1166_CR43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1212\/WNL.62.2.181","volume":"62","author":"TJ Ferman","year":"2004","unstructured":"Ferman TJ, Smith GE, Boeve BF, Ivnik RJ, Petersen RC, Knopman D, et al. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology. 2004;62:181\u20137.","journal-title":"Neurology"},{"key":"1166_CR44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1468-1331.2009.02854.x","volume":"17","author":"YK Kim","year":"2010","unstructured":"Kim YK, Yoon IY, Kim JM, Jeong SH, Kim KW, Shin YK, et al. The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder. Eur J Neurol. 2010;17:487\u201392.","journal-title":"Eur J Neurol"},{"issue":"Suppl 3","key":"1166_CR45","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1016\/S1353-8020(08)70041-5","volume":"13","author":"AJ Stoessl","year":"2007","unstructured":"Stoessl AJ. Positron emission tomography in premotor Parkinson\u2019s disease. Parkinsonism Relat Disord. 2007;13(Suppl 3):S421\u20134.","journal-title":"Parkinsonism Relat Disord"},{"key":"1166_CR46","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.56.9.1143","volume":"56","author":"DS Knopman","year":"2001","unstructured":"Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1143\u201353.","journal-title":"Neurology"},{"key":"1166_CR47","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1212\/WNL.54.5.1050","volume":"54","author":"IG McKeith","year":"2000","unstructured":"McKeith IG, Ballard CG, Perry RH, Ince PG, O\u2019Brien JT, Neill D, et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology. 2000;54:1050\u20138.","journal-title":"Neurology"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-017-1166-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-017-1166-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-017-1166-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T13:20:36Z","timestamp":1494854436000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-017-1166-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,30]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["1166"],"URL":"https:\/\/doi.org\/10.1007\/s12149-017-1166-3","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,30]]}}}